Skip to main content
Premium Trial:

Request an Annual Quote

Serologicals Shareholders Approve Millipore's $1.4B Buyout

NEW YORK (GenomeWeb News) - Serologicals shareholders have approved Millipore's buyout offer, Serologicals said today.
 
GenomeWeb News on April 25 reported Millipore's plan to acquire Serologicals for $1.4 billion. The shareholders will receive $31.55 per share in cash.
 
About 82 percent of shares outstanding voted in favor of the deal, the Atlanta-based company said.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.